Evidence map›Paper›PMID 42637897›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2026

Stochastic vibration and early weight growth in opioid-exposed newborns: a randomized trial.

Elisabeth Bloch-Salisbury, Nicolas Rodriguez, Tory Bruch, Lauren McKenna, Matthew Derbin, Dane Netherton, Toby Yanowitz, Sue R Beers, Mark Vining, James D Wilson

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02801331 (A Randomized Controlled Study of Stochastic Vibrotactile Stimulation for Neonatal Abstinence Syndrome), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02801331 nacompletednot on this map

A Randomized Controlled Study of Stochastic Vibrotactile Stimulation for Neonatal Abstinence Syndrome: Therapeutic Efficacy and Neurobehavioral Outcomes

TypeinterventionalSponsorElisabeth B SalisburyRan2017 to 2021Enrolled208ConditionsNeonatal Abstinence SyndromeArmsStochastic Vibrotactile Stimulation (SVS)
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elisabeth Bloch-SalisburyDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Salisburye2@upmc.edu.ORCID http://orcid.org/0000-0002-7708-3428
Nicolas RodriguezDepartment of Pediatrics, UMass Chan Medical School, Worcester, MA, USA.
Tory BruchDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Lauren McKennaDepartment of Pediatrics, UMass Chan Medical School, Worcester, MA, USA.
Matthew DerbinDepartment of Pediatrics, UMass Chan Medical School, Worcester, MA, USA.
Dane NethertonDepartment of Quantitative and Health Sciences, UMass Chan Medical School, Worcester, MA, USA.
Toby YanowitzDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-3973-0559
Sue R BeersDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mark ViningDepartment of Pediatrics, UMass Chan Medical School, Worcester, MA, USA.
James D WilsonDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Funding

Stochastic vibro-tactile stimulation: A non-pharmacological intervention for abstinence and drug withdrawal in newborn infantsR01DA042074 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SALISBURY, ELISABETH BLOCH · 2016 to 2020
$3.1M
U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DA042074
6 · The paper itself

Abstract

objectiveTo test whether stochastic vibrotactile stimulation (SVS) improved early weight trajectories in hospitalized term newborns with prenatal opioid exposure. STUDY

designThis prospective, two-site randomized controlled trial compared days to lowest weight following birthweight [Nadir], maximal percent weight loss from birthweight [MaxLoss], days to return to birthweight [RtB], and weekly percent weight change from birth through the first month of life between infants who received treatment as usual (TAU) and infants who received SVS throughout hospitalization.

resultsAmong 181 term newborns [mean gestational age 39.0 ± 1.2weeks), no differences were observed between TAU (n = 87) and SVS (n = 94) for Nadir, MaxLoss, or RtB. Among symptomatic infants treated with morphine, mean weight gain at four weeks was significantly greater for SVS (29.88 ± 1.02%) than TAU (18.15 ± 7.31%; p < 0.05).

conclusionsAmong morphine-treated infants, the SVS cohort had greater early weight growth than the TAU cohort. Weight growth via SVS has implications for reduced morbidities and improved developmental outcomes in at-risk opioid-exposed newborns. CLINICAL TRIAL REGISTRY: June 6, 2016, clinicaltrials.gov NCT02801331 ( https://clinicaltrials.gov/study/NCT02801331 ).

Identifiers

PMID42637897

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.